Cutaneous leishmaniasis in Afghanistan
Transactions of The Royal Society of Tropical Medicine and Hygiene · 2025
DOI: 10.1093/trstmh/traf028 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transactions of The Royal Society of Tropical Medicine and Hygiene, 2025. Verfasst von Bilal Ahmad Rahimi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Faculty of Medicine, Kandahar University, Kandahar 3801, Afghanistan. Hauptthemen laut MEDLINE: Leishmaniasis, Cutaneous, Antiprotozoal Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Wellcome Trust, Wellcome.
Abstract (Originalsprache)
Old World cutaneous leishmaniasis (OWCL) is a sand fly-transmitted skin infection caused by Leishmania species that extends from West Africa to China. Afghanistan probably has the highest burden of OWCL and is home chiefly to Leishmania tropica and Leishmania major, which cause anthroponotic and zoonotic CL, respectively. Although data on the species distribution in Afghanistan are patchy, L. tropica predominates over L. major, reflecting its concentration in large cities. CL prevalence in Afghanistan increases with increasing age to peak at 5–10 y, depending on the local epidemiology. Clinically, there is a spectrum of lesions common to both main species with nodules, ulcerated nodules and papules accounting for the majority (50–80%) of lesions at presentation. When healed, CL lesions leave pale scars that often have deleterious psychosocial effects. Leishmania control involves vector control and treating patients, but these are severely challenged by decades of war and disruption to the health system. In the public sector, only injectable antimonials, sodium stibogluconate or meglumine antimoniate, are available and, anecdotally, efficacy remains high. Few clinical trials have been conducted in Afghanistan and data support antimonial efficacy; small clinical series suggest good efficacy of oral miltefosine against the two main species. Herein, we focus our review on the epidemiological and clinical aspects of CL in Afghanistan and suggest avenues of future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Faculty of Medicine, Kandahar University, Kandahar 3801, Afghanistan.
- Department of Medical Micriobiology, Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz 71348-14336, Iran.
- Department of Malaria, National Malaria & Other Vector Borne Diseases Program, Ministry of Public Health, Kabul 1001, Afghanistan.
- Médecins Sans Frontières, Amsterdam 14 1018, the Netherlands.
- Department of Pathology and Laboratory Medicine, Aga Khan University Hospital, Karachi 74800, Pakistan.
- Mahidol Oxford Tropical Medicine Clinical Research Unit, Bangkok 10400, Thailand.
ORCID-Profile: Bilal Ahmad Rahimi
Förderung
- Wellcome Trust
- Wellcome
Zitieren
APA
Rahimi, B. A., Ghatee, M. A., Habib, M. N., Farooqi, K., Ritmeijer, K., Hussain, H. S., Beg, M. A., & Taylor, W. R. (2025). Cutaneous leishmaniasis in Afghanistan. Transactions of The Royal Society of Tropical Medicine and Hygiene. https://doi.org/10.1093/trstmh/traf028
Vancouver
Rahimi BA, Ghatee MA, Habib MN, Farooqi K, Ritmeijer K, Hussain HS, et al. Cutaneous leishmaniasis in Afghanistan. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2025. doi:10.1093/trstmh/traf028
BibTeX
@article{Rahimi2025,
author = {Rahimi, Bilal Ahmad and Ghatee, Mohammad Amin and Habib, Muhammad Naeem and Farooqi, Khushhal and Ritmeijer, Koert and Hussain, Huma Syed and Beg, M Asim and Taylor, Walter R},
title = {Cutaneous leishmaniasis in Afghanistan},
journal = {Transactions of The Royal Society of Tropical Medicine and Hygiene},
year = {2025},
doi = {10.1093/trstmh/traf028}
}
EUVIMED